Pituitary Apoplexy Following Gonadotropin‐Releasing Hormone Agonist Administration for Prostate Cancer

20261 citationsJournal Articlegold Open Access

Authors

Masaaki Fujimura · Chibaken Saiseikai Narashino Hospital

Takahiro Shimizu · Chiba University Hospital

Shinichi Sakamoto · Chiba University Hospital

Hiroaki Sato · Chibaken Saiseikai Narashino Hospital

Hiroyoshi Suzuki · Toho University

Kazuo Mikami · Chibaken Saiseikai Narashino Hospital

Abstract

Clinicians should be aware of the association of pituitary apoplexy with the use of gonadotropin-releasing hormone agonist and should ask about the patient's past history of multiple endocrine neoplasia (MEN).

Topics & Keywords

Pituitary Gland Disorders and Treatments Growth Hormone and Insulin-like Growth Factors Neuroendocrine Tumor Research Advances

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: IJU Case Reports

Volume 9, Issue 2, pp. e70159-e70159

DOI: 10.1002/iju5.70159

Field-Weighted Citation Impact: 32.84